Notice of Results

RNS Number : 2203A

Genus PLC

27 January 2011

 



For Immediate Release

27 January 2011

 

 

Genus plc

Notification of Interim Results

for the six months ended 31 December 2010

Genus, a leading global animal genetics company, will announce its interim results for the six months ended 31 December 2010 on Tuesday, 22 February 2011.

A briefing for analysts will be held at 10:00am on 22 February 2011 at Peel Hunt, 111 Old Broad Street, London EC2N 1PH.

For further information please contact:

Buchanan Communications                Tel: [phone]

Charles Ryland

Suzanne Brocks

Helen Chan

About Genus

Genus plays a key role in the world's agricultural economy in its creation of advances in animal breeding through naturally applied biotechnology, helping farmers and food producers across the world to improve quality and increase output.

Genus provides superior natural animal genetics, enabling our global customers in the bovine and porcine supply chain to produce offspring in their herds with greater production efficiency, milk and meat output and quality. The challenge of meeting growing global demand for milk, pork and beef from the decreasing resources available for food production requires innovative solutions that Genus provides. 

Genus' worldwide sales are made in seventy countries under the trade marks "ABS" (dairy and beef cattle) and "PIC" (pigs) and comprise semen and breeding animals with superior genetics to those animals currently in production. 

Genus' competitive edge has been created from the ownership and control of proprietary lines of breeding animals and the biotechnology used to improve them. Genus' global production and distribution network underpins our unique position in the world's growing agricultural markets.

Headquartered in Basingstoke, England, Genus is a FTSE250 company that operates in 30 countries on six continents, with research laboratories located in Madison, Wisconsin, USA.

 

END

 

 

NORDKODPPBKDADB